Europe Digital Health Market Size and Share

Europe Digital Health Market Summary
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
View Global Report

Europe Digital Health Market Analysis by Mordor Intelligence

Europe digital health market size in 2026 is estimated at USD 113.94 billion, growing from 2025 value of USD 96.68 billion with 2031 projections showing USD 258.74 billion, growing at 17.85% CAGR over 2026-2031. Demand gains stem from post-pandemic telemedicine normalization, swift regulatory harmonization under the European Health Data Space, and record-level public funding for AI-enabled care delivery. Germany’s DiGA reimbursement pathway, France’s PECAN fast-track, and the United Kingdom’s GBP 3.4 billion NHS technology budget are accelerating enterprise-class platform rollouts. Cloud infrastructure already underpins more than half of all deployments, signaling a shift away from bespoke on-premise solutions toward scalable ecosystems that meet divergent country rules. Competitive intensity remains high because clinical use cases still favor best-of-breed applications, yet platform vendors are consolidating through partnerships aimed at cross-border interoperability.

Key Report Takeaways

  • By component, services led with 38.34% revenue share in 2025; software is projected to expand at an 18.6% CAGR through 2031.
  • By technology, telehealth held 46.55% of Europe digital health market share in 2025, while mHealth is set to grow at 18.78% CAGR to 2031.
  • By end user, patients and consumers accounted for 42.10% of Europe digital health market size in 2025; payers show the highest CAGR at 18.55% for 2026-2031.
  • By mode of delivery, cloud-based models captured 56.90% of Europe digital health market share in 2025; on-premise deployments are forecast to rise at 18.95% CAGR.
  • By application, chronic disease management led with 28.25% revenue share in 2025, whereas fitness and wellness applications are poised for 19.18% CAGR through 2031.
  • Germany, France, and the United Kingdom together represented 57.45% of 2025 revenue, with Germany alone holding 23.10% of Europe digital health market size. 

Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026.

Segment Analysis

By Component: Services Dominate While Software Accelerates

Services retained 38.34% revenue in 2025 because Europe’s heterogeneous health-system landscape requires extensive customization and change management. Yet software revenue is set to grow at an 18.6% CAGR, signalling migration toward configurable platforms that minimize repetitive consulting engagements. Hardware continues to post steady orders for connected sensors and imaging peripherals, aided by EU funding schemes that subsidize device upgrades eligible for hospital modernisation grants.

The component mix reflects a transitional phase where hospitals replace siloed applications with unified interoperability suites. Siemens Healthineers’ Teamplay Digital Health Platform added AI diagnostic modules and discharge-planning tools in 2024, enabling providers to license new functionality without extra integration overhead . Such plug-in ecosystems reduce total cost of ownership and accelerate multi-country rollouts. Continued software expansion is expected to raise software’s share of Europe digital health market size to over 32% by 2031.

Europe Digital Health Market: Market Share by Component, 2025
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Europe Digital Health Market: Market Share by Component, 2025

By Technology: Telehealth Leadership Faces mHealth Disruption

Telehealth accounted for 46.55% of Europe digital health market size in 2025 thanks to permanent reimbursement codes and clinician familiarity with video workflows. mHealth, however, is projected to deliver the fastest 18.78% CAGR as smartphone penetration exceeds 90% and payers reimburse evidence-based digital therapeutics. Analytics and digital health systems gain momentum as AI image reconstruction and clinical-decision support are mandated under several hospital-investment frameworks.

Consumer uptake fuels the shift: Philips SmartSpeed Precise MRI, powered by dual AI engines, shortens scan times by 3× and improves image clarity by 80%. Simultaneously, Omron’s acquisition of Luscii extends remote-monitoring capabilities to 150 disease pathways, allowing clinicians to adjust regimens using real-time data feeds. These cross-device integrations intensify technology competition, particularly in chronic-care verticals.

By End User: Patient Empowerment Reshapes Demand

Patients and consumers held 42.10% of 2025 revenue, benefiting from direct-to-customer subscription models and nationwide appointment-booking portals. Payers are poised for the strongest 18.55% CAGR as value-based contracting rewards platforms that prove cost offsets and carbon-footprint reductions. Providers still command sizable budget authority, but funding is increasingly ring-fenced for solutions demonstrating measurable productivity gains.

Germany’s Digital Health Care Act (DVG) lets certified apps secure reimbursement for roughly 90% of the insured population, setting a template for other jurisdictions. Evidence from remote-monitoring trials shows 97% lower CO₂ emissions than in-clinic screening while maintaining quality outcomes. As environmental reporting grows compulsory, payers prefer digital pathways that meet both clinical and sustainability targets, expanding uptake throughout the Europe digital health industry.

By Mode of Delivery: Cloud Infrastructure Anchors Scalability

Cloud-based solutions captured 56.90% of Europe digital health market share in 2025 as providers embraced elastic compute, managed security, and rapid feature release cycles. On-premise models, though smaller, are forecast to post 18.95% CAGR because high-risk AI and genomic datasets often remain within sovereign data centers to satisfy GDPR and forthcoming AI-Act stipulations.

Philips broadened its Imaging Cloud on Amazon Web Services in February 2025, giving European clinicians remote access to radiology studies on a single federated platform. Hybrid architectures that cache sensitive data locally but orchestrate analytics in the cloud are gaining traction, fulfilling the European Health Data Space security tiers. Vendors able to deliver identical user experiences across both deployment modes win multi-country tenders.

Europe Digital Health Market: Market Share by Mode of Delivery, 2025
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Europe Digital Health Market: Market Share by Mode of Delivery, 2025

By Application: Chronic Disease Platforms Take the Lead

Chronic disease management generated 28.25% of revenue in 2025 and remains a cornerstone of national e-health roadmaps. Fitness and wellness apps are set for the swiftest 19.18% CAGR, buoyed by wearable sensors that translate activity data into preventive care insights. Remote patient monitoring, diagnostics, medication adherence, and hospital workflow solutions round out the portfolio.

The European Cancer Imaging Initiative will provide more than 100,000 anonymized cases and at least 50 AI algorithms by 2025, fast-tracking diagnostic AI adoption. Hospital workflow modules likewise gain momentum: Siemens’ Luminos Q.namix integrates dose tracking and staffing dashboards to raise radiology productivity. Integration depth across these applications underpins a holistic continuum-of-care approach.

Geography Analysis

Germany sustained its leadership with 23.10% of Europe digital health market share in 2025, underpinned by 64 DiGA-approved applications that generated over EUR 125 million in reimbursable revenue. The Krankenhauszukunftsfonds finances cybersecurity and interoperability upgrades for 1,900 hospitals, anchoring demand through 2027. Electronic patient records (ePA) became mandatory on an opt-out basis in January 2025, creating a nationwide data backbone that accelerates vendor scale-up.

The United Kingdom recorded the highest 19.25% CAGR outlook to 2031, supported by a GBP 3.4 billion NHS technology envelope focused on a unified patient record and ambient-voice clinical documentation pilots. Regulatory sandboxes administered by the Medicines and Healthcare products Regulatory Agency streamline AI device approval, fostering a vibrant start-up pipeline. However, departmental restructuring of NHS England in 2025 may create interim funding volatility.

France, Italy, and Spain illustrate different adoption curves. France formalized teleconsultation billing and launched the PECAN fast track that reimburses evidence-based apps within six weeks. Italy’s EUR 15.62 billion community-care digitalization plan targets 1,350 local health hubs, yet regional skill gaps slow execution. Spain relies heavily on EU structural funds for e-prescription expansion, while Nordic states maintain near-universal electronic record use, enabling early pilots in cross-border data exchange.

Regulatory Landscape

The European regulatory stack for digital health is being reshaped by EU-wide data and AI rules. The European Health Data Space (EHDS) Regulation (EU) 2025/327 entered into force on 26 March 2025, setting a phased pathway for standardized electronic health record usage and data access governance, with Member States required to designate national digital health authorities by 26 March 2027.

Implementation governance tightened in 2026. Commission Implementing Regulation (EU) 2026/771 established the EHDS Board on 7 April 2026 to coordinate consistent application and technical guidance across countries. In parallel, the EU AI Act (Regulation (EU) 2024/1689) sets high-risk AI obligations relevant to healthcare software, which reinforces formal risk management, human oversight, and impact assessment expectations for AI-enabled clinical workflows as core procurement and certification considerations.

Value Chain Analysis

Europe digital health value creation starts with device and data capture (wearables, imaging systems, bedside monitoring, and patient-reported outcomes), then flows through connectivity and identity layers (provider networks, consent, eID, and cross-border services), into platform software (EHRs, telehealth, analytics, and digital therapeutics), followed by implementation services (integration, cybersecurity, and change management), and finally purchasing and reimbursement by providers and payers. The EHDS accelerates standardization of this chain through common infrastructure and formats, with MyHealth@EU enabling cross-border primary use (for example ePrescriptions and patient summaries) and HealthData@EU enabling multi-country secondary-use requests.

The vendor layer is shifting toward sovereign and interoperable backbones, alongside closer pharma-tech collaboration. In January 2026, SAP and Fresenius announced a strategic partnership to build a digital healthcare backbone using AI, reflecting data residency and interoperability priorities. On the commercialization side, partnerships such as GAIA and Daiichi Sankyo Europe (February 2026) around a cardiovascular digital therapeutic, and Google with DocMorris (March 2026) to migrate pharmacy infrastructure to Google Cloud and apply Gemini models for a digital health companion, position pharmacies, medtech, and life sciences as distribution and engagement nodes alongside hospitals.

Competitive Landscape

Europe’s vendor ecosystem is fragmented: the top five suppliers control under 20% of total revenue, leaving ample room for regional specialists. Market leaders leverage multi-modal AI portfolios, compliance expertise, and cloud alliances to secure framework agreements. Siemens Healthineers’ Teamplay Connect added wound-management and discharge modules in December 2024, strengthening its platform moat. Philips counters with AI-augmented SmartSpeed MRI and imaging cloud distribution on AWS, ensuring modality breadth and rapid update cycles.

Device manufacturers increasingly acquire software IP: Omron’s 2024 purchase of Luscii gives it instant scale in remote-monitoring protocols across 70% of Dutch hospitals. Start-ups differentiate through vertical depth—exemplified by digital therapeutics for mental health and metabolic disease—yet must navigate complex multi-country reimbursement. Platforms that embed pre-configured GDPR and AI-Act controls gain procurement preference, shrinking the addressable market for point solutions.

Consolidation is expected as funding tightens: cross-border mergers allow firms to pool regulatory talent and achieve the ISO-certified design controls required by high-risk AI legislation. Meanwhile, telecom operators and cloud hyperscalers partner with hospital groups to deliver edge-compute services, signaling non-traditional entrants’ interest in capturing infrastructure layers of the Europe digital health market.

Europe Digital Health Industry Leaders

  1. Koninklijke Philips NV

  2. AMD Global Telemedicine Inc.

  3. Allscripts Healthcare Solutions Inc.

  4. International business Machinery Corporation (IBM)

  5. Cerner Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Europe Digital Health Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Market Opportunities and Future Outlook

EHDS compliance work is creating a clear whitespace for interoperability-ready EHR modules, testing, and documentation packages that reduce time-to-procurement for multi-country deployments. The governance setup advanced in April 2026 when the European Commission established the EHDS Board under Implementing Regulation (EU) 2026/771, and multiple governments moved in parallel with national data-space and EHR initiatives. This includes Spain launching its National Health Data Space (ENDS) with EUR 70 million in January 2026 and Ireland approving procurement to commence for a national electronic health record in February 2026. Together, these programs broaden demand for consent management, identity, secure data exchange, and audit tooling aligned to EU-level specifications.

Advanced-care opportunities are being pursued by public-private consortia and clinical programs that operationalize AI and remote monitoring at scale. Examples include GE HealthCare taking a lead industrial role in the EUR 50.5 million COMPASS consortium (March 2026) for precision cardio-oncology, the IMPACT-MED project coordinated by UCBM and Medtronic starting a 60-month initiative focused on AI-based hypertension and cardiovascular remote monitoring (May 2026), and the TWIN-X project launching with EUR 15 million in Horizon Europe funding (June 2026) to advance trustworthy digital twins. These initiatives open vendor opportunities in regulated AI development, data pipelines, and workflow integration across imaging, chronic-care, and hospital-at-home pathways.

Recent Industry Developments

  • July 2026: Smartpatient and Novo Nordisk launched an expanded direct-to-patient digital support program for type 2 diabetes in Germany using the MyTherapy platform. The program strengthens manufacturer-sponsored adherence and lifestyle support as a distribution channel, and it increases demand for secure patient engagement, data capture, and integration with care teams.
  • February 2025: Philips expanded its radiology informatics cloud on Amazon Web Services to European data centers, enabling remote diagnostic reading with integrated AI post-processing. The expansion supports multi-site radiology networks and reinforces cloud-based delivery models for imaging workflows under Europe-specific data residency and security needs.
  • April 2024: Omron Healthcare completed its acquisition of Luscii, adding multi-condition remote monitoring software deployed in a large share of Netherlands hospitals. The acquisition accelerated convergence between connected devices and clinical monitoring software, raising competitive pressure on stand-alone RPM vendors and strengthening end-to-end chronic-care offerings.

Table of Contents for Europe Digital Health Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 EU Funding & Regulatory Push
    • 4.2.2 Ageing Population Driving Chronic-Care Demand
    • 4.2.3 Telehealth Normalisation Post-Covid-19
    • 4.2.4 Cross-Border Eprescription & eID Interoperability
    • 4.2.5 Germany’S “Hospital-At-Home” Reimbursement Model
    • 4.2.6 Mdr-Compliant Ai Software Demand
  • 4.3 Market Restraints
    • 4.3.1 Gdpr-Driven Data-Privacy Complexity
    • 4.3.2 High Upfront Digitalisation Costs For Smes
    • 4.3.3 Fragmented Reimbursement Across Eu-27
    • 4.3.4 Digital-Skill Gaps In Clinical Workforce
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter’s Five Forces Analysis
    • 4.7.1 Bargaining Power of Buyers
    • 4.7.2 Bargaining Power of Suppliers
    • 4.7.3 Threat of New Entrants
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Component
    • 5.1.1 Hardware
    • 5.1.2 Software
    • 5.1.3 Services
  • 5.2 By Technology
    • 5.2.1 Telehealth
    • 5.2.2 mHealth
    • 5.2.3 Health Analytics
    • 5.2.4 Digital Health Systems
  • 5.3 By End User
    • 5.3.1 Healthcare Providers
    • 5.3.2 Payers
    • 5.3.3 Patients & Consumers
  • 5.4 By Mode of Delivery
    • 5.4.1 On-premise Delivery
    • 5.4.2 Cloud-based Delivery
  • 5.5 By Application
    • 5.5.1 Chronic Disease Management
    • 5.5.2 Remote Patient Monitoring
    • 5.5.3 Fitness & Wellness
    • 5.5.4 Diagnostics & Imaging
    • 5.5.5 Medication Management
    • 5.5.6 Hospital Workflow Management
  • 5.6 Geography
    • 5.6.1 Germany
    • 5.6.2 United Kingdom
    • 5.6.3 France
    • 5.6.4 Italy
    • 5.6.5 Spain
    • 5.6.6 Rest of Europe

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 Allscripts Healthcare Solutions Inc.
    • 6.3.2 IBM Corp.
    • 6.3.3 AMD Global Telemedicine Inc.
    • 6.3.4 Koninklijke Philips N.V.
    • 6.3.5 Teladoc Health Inc.
    • 6.3.6 Aerotel Medical Systems Ltd.
    • 6.3.7 Cerner Corp.
    • 6.3.8 eClinicalWorks LLC
    • 6.3.9 McKesson Corp.
    • 6.3.10 Cisco Systems Inc.
    • 6.3.11 CompuGroup Medical SE
    • 6.3.12 Siemens Healthineers AG
    • 6.3.13 Babylon Health
    • 6.3.14 Doctolib SAS
    • 6.3.15 Ada Health GmbH
    • 6.3.16 Infermedica Sp. z o.o.
    • 6.3.17 Medtronic plc
    • 6.3.18 Roche Diagnostics
    • 6.3.19 Health Catalyst Inc.
    • 6.3.20 Dedalus Group

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-need Assessment

Research Methodology Framework and Report Scope

Market Definition and Coverage

For this methodology, the market covers digital tools and services used across Europe to prevent, diagnose, treat, monitor, and manage health conditions, including care delivery, data-driven workflows, and patient engagement that is clinically linked.

Scope exclusions: We exclude general fitness and wellness apps that are not connected to clinical care pathways or medically guided monitoring.

Segmentation Overview

  • By Component
    • Hardware
    • Software
    • Services
  • By Technology
    • Telehealth
    • mHealth
    • Health Analytics
    • Digital Health Systems
  • By End User
    • Healthcare Providers
    • Payers
    • Patients & Consumers
  • By Mode of Delivery
    • On-premise Delivery
    • Cloud-based Delivery
  • By Application
    • Chronic Disease Management
    • Remote Patient Monitoring
    • Fitness & Wellness
    • Diagnostics & Imaging
    • Medication Management
    • Hospital Workflow Management
  • Geography
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe

Data Sources, Market Sizing, and Validation

Desk Research

Desk research started with public health and digital policy materials that help set consistent boundaries across countries, followed by demand signals that show how digital care is being used in practice. We relied on sources such as Eurostat for demographic and health system indicators, OECD health data for spending and access patterns, the European Commission for digital health and data policy direction, and WHO Europe publications for health trends and service delivery priorities.

To ground the commercial side, we reviewed company filings and investor presentations where available, along with association websites and reputable press coverage on reimbursement moves and digital adoption. Supporting datasets from paid subscriptions were used selectively for company financials, news screening, and patent activity checks, mainly to sanity-check growth stories and identify the timing of product rollouts. The sources listed here are illustrative, and many other public references were used to collect data, validate assumptions, and clarify unclear points.

Primary Interviews and Surveys

Primary work focused on validating what is counted as paid digital health revenue, how purchasing happens, and how usage translates into budgets across European care settings. We spoke with a mix of solution providers, healthcare delivery stakeholders, and channel or integration partners. We then tested uncertain inputs like adoption pace, pricing changes, and procurement cycles across major European markets and the rest of the region.

Distribution of primary research fieldwork respondents

Company typeRespondent positionRegion
Top tier: 34% CXOs: 13%
Mid tier: 47% Functional/Unit leaders: 34%
Smaller Players: 19% Managers: 53%

Market-Sizing & Forecasting

Sizing started from a top-down build where health IT and digital care spending pools were reconstructed using healthcare expenditure, digital adoption intensity by country, and the mix shift toward remote and data-supported care. Once these totals were formed, we corroborated them with selective bottom-up checks, such as sampled vendor revenue disclosures, typical subscription or service pricing, and volume proxies like teleconsultation usage where it is publicly discussed. These checks were used to adjust outliers.

Inputs used in the model included items like reimbursement and funding support for digital services, cloud versus on-premise deployment mix, patient access constraints that drive remote care, and the country-level rollout speed for electronic records and related digital systems. Forecasts were built using scenario analysis, where growth paths were tied to a small set of variables that interviewees could realistically validate, including budget cycles, regulatory timing, and the pace of provider workflow digitization. When bottom-up signals were missing for smaller countries or smaller providers, we applied coverage ratios derived from comparable markets and then rechecked the totals against regional demand indicators.

Data Validation & Update Cycle

Model outputs were cross-checked against independent signals, such as public digital health initiatives, health spending trends, and the expected timing of policy or reimbursement shifts. We then reviewed results again for any unusual jumps by country or technology group. If a number moved outside a reasonable range, we revisited the assumptions and, when needed, re-contacted selected experts to confirm whether the change reflected a real market event.

Before sign-off, the work is reviewed in multiple steps so that calculation logic, unit consistency, and currency conversions are aligned across the full time series. The report is refreshed annually, and interim updates are made when material events occur, with a final pre-delivery pass to ensure clients receive the latest updated view.

Mordor Intelligence's Europe Digital Health Market Size Compared Against Other Published Estimates

Published values for Europe digital health often differ because studies do not always count the same revenue streams, they may use different time bases for currency conversion, and they can apply different adoption or price progression assumptions.

Consumer-only wellness subscriptions sit outside Mordor Intelligence's scope here, which is one reason totals can look higher in studies that blend lifestyle spend with clinically linked digital tools and services.

Benchmark comparison

SourceMarket SizeGaps in Research Methodology
Mordor Intelligence USD 96.68 B (2025)
Industry Research House A USD 88.86 B (2024)Uses an earlier base year and a wider platform definition in some cases, and the year shift also changes inflation and FX translation, which can pull the 2025 comparable value away from ours.
Trade Journal B USD 32.07 B (2022)Relies on an older starting point and a narrower monetized set of digital solutions, which can undercount newer revenue pools like cloud-based delivery and analytics-driven services.

Across the three figures, the spread mainly comes from what is included as paid digital health revenue, the year used for the market snapshot, and how fast pricing and adoption are assumed to move. By keeping the scope tied to clinically linked digital tools and then testing the assumptions with direct market feedback, the resulting number stays traceable to clear drivers and can be repeated with the same steps next year.

Key Questions Answered in the Report

How big is the Europe Digital Health Market?

The Europe Digital Health Market size is expected to reach USD 113.94 billion in 2026 and grow at a CAGR of 17.85% to reach USD 258.74 billion by 2031.

Which component segment is growing fastest?

Software is forecast to expand at an 18.6% CAGR, reflecting a move toward configurable platforms across the region.

Who are the key players in Europe Digital Health Market?

Koninklijke Philips NV, AMD Global Telemedicine Inc., Allscripts Healthcare Solutions Inc., International business Machinery Corporation (IBM) and Cerner Corporation are the major companies operating in the Europe Digital Health Market.

How large is Germany’s share of the Europe digital health market?

Germany accounts for 23.10% of total 2025 revenue, anchored by its DiGA reimbursement framework.

Page last updated on:

Europe Digital Health Report Snapshots